// App-Quantinova.ai

CTP29 : Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TO-ACT trial)

Researchers

Presenter

  • Jose M Ferro

Principal Investigators

  • Susanna M. Zuurbier

  • Patricia Canhao

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Hospital de Santa Maria, Lisbon, Portugal

Locations

  • Portugal

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • open label

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved